Literature DB >> 22679125

Investigating systematic misclassification of central line-associated bloodstream infection (CLABSI) to secondary bloodstream infection during health care-associated infection reporting.

Nicola D Thompson1, Lan Lan L Yeh, Shelley S Magill, Stephen M Ostroff, Scott K Fridkin.   

Abstract

Central line-associated bloodstream infection (CLABSI) rates are an important measure of health care quality. However, reputational or financial risks associated with public reporting and disclosure of hospital CLABSI rates may introduce reporting biases, including intentional underreporting. To assess systematic case misclassification of CLABSI to secondary bloodstream infection (BSI; ie, intentional underreporting of CLABSI), the authors assessed data reported to the National Healthcare Safety Network by hospitals in Pennsylvania, the only state in which both CLABSI and secondary BSI reporting are mandatory. CLABSI rates decreased over the 2-year analysis period, but the authors found no evidence of increasing secondary BSI rates, suggesting that systematic case misclassification is not widespread.

Mesh:

Year:  2012        PMID: 22679125     DOI: 10.1177/1062860612442565

Source DB:  PubMed          Journal:  Am J Med Qual        ISSN: 1062-8606            Impact factor:   1.852


  6 in total

1.  The association of state legal mandates for data submission of central line-associated bloodstream infections in neonatal intensive care units with process and outcome measures.

Authors:  Philip Zachariah; Julie Reagan; E Yoko Furuya; Andrew Dick; Hangsheng Liu; Carolyn T A Herzig; Monika Pogorzelska-Maziarz; Patricia W Stone; Lisa Saiman
Journal:  Infect Control Hosp Epidemiol       Date:  2014-07-25       Impact factor: 3.254

2.  ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014-2019.

Authors:  Can Huseyin Hekimoglu; Serap Suzuk Yildiz; Selda Sahan; Esen Batir; Emine Yildirim Gozel; Dilek Altun; Gulen Pehlivanturk; Muhammet Comce; Fatih Kara
Journal:  GMS Hyg Infect Control       Date:  2022-04-11

3.  The evolving landscape of healthcare-associated infections: recent advances in prevention and a road map for research.

Authors:  Nasia Safdar; Deverick J Anderson; Barbara I Braun; Philip Carling; Stuart Cohen; Curtis Donskey; Marci Drees; Anthony Harris; David K Henderson; Susan S Huang; Manisha Juthani-Mehta; Ebbing Lautenbach; Darren R Linkin; Jennifer Meddings; Loren G Miller; Aaron Milstone; Daniel Morgan; Sharmila Sengupta; Meera Varman; Deborah Yokoe; Danielle M Zerr
Journal:  Infect Control Hosp Epidemiol       Date:  2014-05       Impact factor: 3.254

Review 4.  Accuracy of administrative data for surveillance of healthcare-associated infections: a systematic review.

Authors:  Maaike S M van Mourik; Pleun Joppe van Duijn; Karel G M Moons; Marc J M Bonten; Grace M Lee
Journal:  BMJ Open       Date:  2015-08-27       Impact factor: 2.692

5.  Central line associated blood stream infection rate after intervention and comparing outcome with national healthcare safety network and international nosocomial infection control consortium data.

Authors:  Sz Bukhari; A Banjar; Ss Baghdadi; Ba Baltow; Am Ashshi; Wm Hussain
Journal:  Ann Med Health Sci Res       Date:  2014-09

6.  Institutional factors associated with the incidence rates of central line-associated bloodstream infection in California community hospitals.

Authors:  Ella Calixta Nelson; Chia-Hui Wang; Garry Huang; Nai-Wen Kuo
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.